Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response. | Curr Oncol | 2023 | 38275827 | PubTator, text mining | PubMed |
| Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma. | Front Endocrinol (Lausanne) | 2023 | 38274225 | PubTator, text mining | PubMed |
| TNIK regulation of interferon signaling and endothelial cell response to virus infection. | Front Cardiovasc Med | 2023 | 38264262 | PubTator, text mining | PubMed |
| Blood-brain barrier breakdown, central nervous system cell damage, and infiltrated T cells as major adverse effects in CAR-T-related deaths: a literature review. | Front Med (Lausanne) | 2023 | 38259840 | PubTator, text mining | PubMed |
| Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model. | Front Immunol | 2023 | 38259442 | PubTator, text mining | PubMed |
| Parenteral Cysteine Supplementation in Preterm Infants: One Size Does Not Fit All. | Biomedicines | 2023 | 38255171 | PubTator, text mining | PubMed |
| Drug resistance in glioblastoma: from chemo- to immunotherapy. | Cancer Drug Resist | 2023 | 38239396 | PubTator, text mining | PubMed |
| Dissecting molecular mechanisms of immune microenvironment dysfunction in multiple myeloma and precursor conditions. | J Cancer Metastasis Treat | 2023 | 38213954 | PubTator, text mining | PubMed |
| A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts. | Int J Mol Sci | 2023 | 38203331 | PubTator, text mining | PubMed |
| Ferroptosis, Metabolic Rewiring, and Endometrial Cancer. | Int J Mol Sci | 2023 | 38203246 | PubTator, text mining | PubMed |
| Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis. | Cancers (Basel) | 2023 | 38201595 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. | Cancers (Basel) | 2023 | 38201473 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances. | Cancers (Basel) | 2023 | 38201469 | PubTator, text mining | PubMed |
| Targeted Immunotherapies for Cancers. | Cancers (Basel) | 2023 | 38201439 | PubTator, text mining | PubMed |
| Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy. | Front Immunol | 2023 | 38193080 | PubTator, text mining | PubMed |
| Using normalization process theory to inform practice: evaluation of a virtual autism training for clinicians. | Front Health Serv | 2023 | 38192729 | PubTator, text mining | PubMed |
| Generation of chimeric antigen receptor macrophages from human pluripotent stem cells to target glioblastoma. | Immunooncol Technol | 2023 | 38192614 | PubTator, text mining | PubMed |
| Current status and future challenges of CAR-T cell therapy for osteosarcoma. | Front Immunol | 2023 | 38187386 | PubTator, text mining | PubMed |
| Oncolytic virotherapy in cancer treatment: challenges and optimization prospects. | Front Immunol | 2023 | 38169820 | PubTator, text mining | PubMed |
| Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells. | Front Immunol | 2023 | 38169746 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=12